Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anneke ten Brinke

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Current Opinion in Allergy and Clinical Immunology|January 12, 2008
Risk factors associated with irreversible airflow limitation in asthmaAnneke ten Brinke
Treatments in Respiratory Medicine|December 13, 2005
A rational approach to the management of severe refractory asthmaElisabeth Bel, Anneke ten Brinke
Chest|June 7, 2017
New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!Elisabeth H Bel, Anneke Ten Brinke
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma"Lianne Ten Have, Kim de Jong, Anneke Ten Brinke
Annals of the American Thoracic Society|September 13, 2023
Effect of Biologic Therapy on Total Body Composition in Severe AsthmaEdith Visser, Lianne Ten Have, Anneke Ten Brinke, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2015
Reply: To PMID 25617224Jantina C de Groot, Anneke ten Brinke, Elisabeth H D Bel
The Journal of Allergy and Clinical Immunology|June 14, 2015
Reply: To PMID 25617224Jantina C de Groot, Anneke ten Brinke, Elisabeth H D Bel
The Journal of Allergy and Clinical Immunology. in Practice|October 18, 2020
Long-Term Therapy Response to Anti-IL-5 Biologics in Severe Asthma-A Real-Life EvaluationKatrien Eger, Johannes A Kroes, Anneke Ten Brinke, et al.
ERJ Open Research|October 13, 2016
Management of the patient with eosinophilic asthma: a new era beginsJantina C de Groot, Anneke Ten Brinke, Elisabeth H D Bel
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2022
Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma"Katrien Eger, Johannes A Kroes, Anneke Ten Brinke, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Current Opinion in Allergy and Clinical Immunology|January 12, 2008
Risk factors associated with irreversible airflow limitation in asthmaAnneke ten Brinke
Treatments in Respiratory Medicine|December 13, 2005
A rational approach to the management of severe refractory asthmaElisabeth Bel, Anneke ten Brinke
Chest|June 7, 2017
New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!Elisabeth H Bel, Anneke Ten Brinke
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma"Lianne Ten Have, Kim de Jong, Anneke Ten Brinke
Annals of the American Thoracic Society|September 13, 2023
Effect of Biologic Therapy on Total Body Composition in Severe AsthmaEdith Visser, Lianne Ten Have, Anneke Ten Brinke, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2015
Reply: To PMID 25617224Jantina C de Groot, Anneke ten Brinke, Elisabeth H D Bel
The Journal of Allergy and Clinical Immunology|June 14, 2015
Reply: To PMID 25617224Jantina C de Groot, Anneke ten Brinke, Elisabeth H D Bel
The Journal of Allergy and Clinical Immunology. in Practice|October 18, 2020
Long-Term Therapy Response to Anti-IL-5 Biologics in Severe Asthma-A Real-Life EvaluationKatrien Eger, Johannes A Kroes, Anneke Ten Brinke, et al.
ERJ Open Research|October 13, 2016
Management of the patient with eosinophilic asthma: a new era beginsJantina C de Groot, Anneke Ten Brinke, Elisabeth H D Bel
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2022
Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma"Katrien Eger, Johannes A Kroes, Anneke Ten Brinke, et al.
Pageof 7